Invention Grant
- Patent Title: Prolonged release pharmaceutical composition comprising cysteamine or salt thereof
-
Application No.: US16084308Application Date: 2017-03-14
-
Publication No.: US11135173B2Publication Date: 2021-10-05
- Inventor: Andrea Gazzaniga , Matteo Cerea , Alessandra Maroni , Marco Barchielli
- Applicant: RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.P.A.
- Applicant Address: IT Milan
- Assignee: RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.P.A.
- Current Assignee: RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.P.A.
- Current Assignee Address: IT Milan
- Agency: Lucas & Mercanti, LLP
- Priority: ITUA2016A001799 20160318
- International Application: PCT/EP2017/055964 WO 20170314
- International Announcement: WO2017/157922 WO 20170921
- Main IPC: A61K9/50
- IPC: A61K9/50 ; A61K31/145
Abstract:
A prolonged release multiple unit dosage form, preferably pellets, of cysteamine, cystamine or a pharmaceutically acceptable salt thereof, preferably cysteamine bitartrate, with a non gastro-resistant coating is described. The dosage form is particularly indicated for the administration to patients once or twice a day and it can be used also for pediatric administration.
Public/Granted literature
- US20190076368A1 PROLONGED RELEASE PHARMACEUTICAL COMPOSITION COMPRISING CYSTEAMINE OR SALT THEREOF Public/Granted day:2019-03-14
Information query
